Creating scientific and strategic clarity
Effective communication unites teams, earns investor trust, and drives successful regulatory interactions.
Stakeholder Engagement and Communication
With experience presenting to boards, managing investor-facing narratives, reviewing key scientific and regulatory documents, and serving as a university instructor, I bring a structured, empathetic communication style that helps stakeholders understand not just what will happen, but why it matters.
As both Chief Science Officer and a member of the board of directors at Entheon Biomedical, I regularly communicated scientific concepts and operational progress to diverse audiences, including investors, shareholders, scientific advisors, clinicians, CROs, and legal teams. My approach has been to listen carefully and understand what matters most to each group, tailoring complex ideas into straightforward narratives and conversations that bring teams together rather than overwhelm them.
Drawing on my experiences teaching physiology and pharmacology at the University of Michigan and the University of British Columbia, I have enjoyed the challenge of translating science and business to people with diverse viewpoints.
